Fidelity Investments’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Fidelity Investments’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-43,500	Closed	-$202K	–	5647
2021 Q4	$202K	Sell	43,500 -170,300	-80%	-$1.17M	﹤0.01%	2956
2021 Q3	$1.65M	Hold	213,800	–	–	﹤0.01%	2606
2021 Q2	$1.84M	Sell	213,800 -219,200	-51%	-$1.93M	﹤0.01%	2565
2021 Q1	$4.92M	Buy	+433,000	New	+$6.79M	﹤0.01%	2264

Other funds holding DBTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return

Fidelity Investments's DBTX Position: Q1 2022 in Review

Fidelity Investments sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q1 2022, closing a stake of 43,500 shares — an estimated $202K sold.

Fidelity Investments first reported a position in DBTX in Q1 2021 and held it in 4 quarters. The position peaked at $4.92M in Q1 2021. 39 funds tracked by Wall St. Rank hold DBTX as of Q1 2022.

Fidelity Investments reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Fidelity Investments sold 43,500 Decibel Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $202K.
Fidelity Investments first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Fidelity Investments's Decibel Therapeutics, Inc. Common Stock position peaked at $4.92M in Q1 2021.
39 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.